CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income	$ 133,881	$ 73,660
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	9,101	10,494
Stock-based compensation expense	6,515	9,254
Inventory impairments and abandonments	935	696
Deferred and other income tax expense	29,683	22,587
Gain on sale of fixed assets	(252)	(258)
Change in allowance for doubtful accounts	(6)	(66)
Equity in income of unconsolidated entities	(454)	(424)
Cash distributions of income from unconsolidated entities	380	66
Gain (loss) on extinguishment of debt, net	78	1,613
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable	554	(3,145)
Decrease in income tax receivable	0	49
Increase in inventory	(351,424)	(54,867)
Increase in other assets	(4,540)	(4,195)
Increase in trade accounts payable	12,473	22,892
(Decrease) increase in other liabilities	(1,428)	186
Net cash (used in) provided by operating activities	(164,504)	78,542
Cash flows from investing activities:
Capital expenditures	(11,192)	(10,319)
Proceeds from sale of fixed assets	257	308
Net cash used in investing activities	(10,935)	(10,011)
Cash flows from financing activities:
Repayment of debt	(7,750)	(25,128)
Repayment of borrowings from credit facility	(80,000)	0
Borrowings from credit facility	80,000	0
Debt issuance costs	0	(427)
Repurchase of common stock	(2,527)	0
Tax payments for stock-based compensation awards	(6,631)	(3,044)
Stock option exercises	5	564
Net cash used in financing activities	(16,903)	(28,035)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(192,342)	40,496
Cash, cash equivalents, and restricted cash at beginning of period	274,143	342,528
Cash, cash equivalents, and restricted cash at end of period	$ 81,801	$ 383,024